← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksATHARevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

ATHA logoAthira Pharma, Inc. (ATHA) Revenue History

Annual and quarterly revenue from 2018 to 2025

TTM Revenue
$0
0
YoY Growth
-
Latest Quarter
$0
Q1 2026
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$0 ()

Loading revenue history...

ATHA Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Peak Annual Revenue$0 (0)

Download Historical Data

8 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ATHA Revenue Analysis (2018–2025)

As of May 8, 2026, Athira Pharma, Inc. (ATHA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.

Looking at the longer-term picture, ATHA's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including ACIU (-86.9% YoY), and NRXP. Compare ATHA vs ACIU →

ATHA Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
ATHA logoATHACurrent$0---
ACIU logoACIU$4M-86.9%-25.4%-1927.3%
NRXP logoNRXP$1M---1324.4%
Best in groupLowest in group

ATHA Historical Revenue Data (2018–2025)

Showing 8 of 8 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$0-$-68,088,000-$-102,266,000-
2024$0-$0-$-100,902,000-
2023$0-$0-$-125,466,000-
2022$0-$0-$-104,016,000-
2021$0-$-479,000-$-64,022,000-
2020$0-$-2,000,000-$-19,995,000-
2019$0-$0-$-5,449,000-
2018$0-$0-$-5,009,000-

See ATHA's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is ATHA Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare ATHA vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

ATHA — Frequently Asked Questions

Quick answers to the most common questions about buying ATHA stock.

Is ATHA's revenue growth accelerating or slowing?

ATHA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.

What is ATHA's long-term revenue growth rate?

Athira Pharma, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is ATHA's revenue distributed by segment?

ATHA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

ATHA Revenue Over Time (2018–2025)